340B Drug Discount Program: Agency Oversight Has Improved, but Actions Needed to Address Weaknesses V. GAO-26-108784

About | HeinOnline Law Journal Library | HeinOnline Law Journal Library | HeinOnline

table,div,span,font,p{display:none}Please click here if you are not redirected within a few seconds.

GAO-26-108784 [i] (October 23, 2025)

handle is hein.gao/drugids0001 and id is 1 raw text is: United States Government Accountability Office
Testimony
Before the Committee on Health,
Education, Labor, and Pensions,
U.S. Senate

For Release on Delivery
Expected at 10:00 am. ET
Thursday, October 23, 2025

340B DRUG DISCOUNT
PROGRAM

Agency Oversight Has
Improved, but Actions
Needed to Address
Weaknesses

Statement of Michelle B. Rosenberg
Director, Health Care

GAO-26-108784